Sucralfate: worldwide experience in recurrence therapy.
International studies have shown sucralfate to be a safe and effective short- and long-term treatment for patients with peptic ulcer. Available data suggest that the more convenient dosage schedule of 2 g b.i.d. may be preferable to the conventional 1 g q.i.d. regimen for short-term duodenal ulcer healing, and that a maintenance dose of 2 g at night may be appropriate in the long-term management of patients with gastric or duodenal ulcer disease. Smoking has no adverse effect on healing in sucralfate-treated duodenal ulcer patients, and sucralfate granules do not appear to be more effective than tablets in ulcer healing.
Marks
I N
IN
D004381:Duodenal Ulcer / Q000188:drug therapy; D006801:Humans; D010437:Peptic Ulcer / Q000188:drug therapy*; D012008:Recurrence; D013276:Stomach Ulcer / Q000188:drug therapy; D013392:Sucralfate / Q000627:therapeutic use*
D013392:Sucralfate